Abstract

BackgroundAKT1 (v-akt murine thymoma viral oncogene homologue 1) kinase is one of the most frequently activated proliferated and survival pathway of cancer. Recently it has been shown that E17K mutation in the Pleckstrin Homology (PH) domain of AKT1 protein leads to cancer by amplifying the phosphorylation and membrane localization of protein. The mutant has shown resistance to AKT1/2 inhibitor VIII drug molecule. In this study we have demonstrated the detailed structural and molecular consequences associated with the activity regulation of mutant protein.MethodsThe docking score exhibited significant loss in the interaction affinity to AKT1/2 inhibitor VIII drug molecule. Furthermore, the molecular dynamics simulation studies presented an evidence of rapid conformational drift observed in mutant structure.ResultsThere was no stability loss in mutant as compared to native structure and the major cation–π interactions were also shown to be retained. Moreover, the active residues involved in membrane localization of protein exhibited significant rise in NHbonds formation in mutant. The rise in NHbond formation in active residues accounts for the 4-fold increase in the membrane localization potential of protein.ConclusionThe overall result suggested that, although the mutation did not induce any stability loss in structure, the associated pathological consequences might have occurred due to the rapid conformational drifts observed in the mutant AKT1 PH domain.General SignificanceThe methodology implemented and the results obtained in this work will facilitate in determining the core molecular mechanisms of cancer-associated mutations and in designing their potential drug inhibitors.

Highlights

  • AKT1 (v-akt murine thymoma viral oncogene homologue 1) kinase is a member of possibly the most frequently activated proliferation and survival pathway in cancer [1,2,3,4,5,6]

  • According to the inferences presented in their work, the mutation causes significant change in the conformation of AKT1 Pleckstrin Homology (PH) domain which leads to over phosphorylation, 4.5 fold rise in its membrane localization tendency and elevation of kinase activity which can lead to cancer [1,2,3,4,5,6]

  • The experimental outcomes have presented the marginal overview of the molecular mechanism associated with E17K mutation, we still lack the detailed explanation of the observed phenotype at molecular and atomic level

Read more

Summary

Introduction

AKT1 (v-akt murine thymoma viral oncogene homologue 1) kinase is a member of possibly the most frequently activated proliferation and survival pathway in cancer [1,2,3,4,5,6]. The loss of associated interacting members such as the phosphatase and tensin homologue (PTEN) lipid phosphatase activity has been reported in glioblastoma, prostate and endometrial cancers by means of somatic mutations [11], or in breast cancer by means of epigenetic silencing [12], which represents an alternative indirect mechanism for activating AKT. AKT1 (v-akt murine thymoma viral oncogene homologue 1) kinase is one of the most frequently activated proliferated and survival pathway of cancer. It has been shown that E17K mutation in the Pleckstrin Homology (PH) domain of AKT1 protein leads to cancer by amplifying the phosphorylation and membrane localization of protein. In this study we have demonstrated the detailed structural and molecular consequences associated with the activity regulation of mutant protein

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.